ICU Medical (NASDAQ:ICUI) Hits New 52-Week Low at $174.84

ICU Medical, Inc. (NASDAQ:ICUIGet Rating) shares reached a new 52-week low on Tuesday . The stock traded as low as $174.84 and last traded at $183.29, with a volume of 2897 shares traded. The stock had previously closed at $201.17.

Several brokerages recently commented on ICUI. StockNews.com cut shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, April 26th. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $245.00 price objective for the company in a research note on Wednesday, April 27th. Finally, Raymond James reduced their price objective on shares of ICU Medical from $286.00 to $265.00 and set an “outperform” rating for the company in a research note on Monday, February 28th.

The stock has a market capitalization of $4.48 billion, a P/E ratio of 42.44 and a beta of 0.48. The stock’s 50 day moving average is $224.55.

ICU Medical (NASDAQ:ICUIGet Rating) last released its quarterly earnings results on Monday, May 9th. The medical instruments supplier reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.04. ICU Medical had a net margin of 7.84% and a return on equity of 8.58%. The business had revenue of $543.10 million during the quarter, compared to analysts’ expectations of $557.33 million. During the same quarter in the previous year, the company earned $1.34 EPS. The business’s quarterly revenue was up 70.8% compared to the same quarter last year. On average, research analysts expect that ICU Medical, Inc. will post 8.61 earnings per share for the current fiscal year.

In other ICU Medical news, CEO Vivek Jain sold 36,000 shares of the business’s stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $240.00, for a total value of $8,640,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 7.30% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Thrivent Financial for Lutherans lifted its holdings in shares of ICU Medical by 51.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 16,858 shares of the medical instruments supplier’s stock worth $3,934,000 after acquiring an additional 5,698 shares during the last quarter. New York State Teachers Retirement System lifted its holdings in shares of ICU Medical by 11.0% in the 4th quarter. New York State Teachers Retirement System now owns 27,851 shares of the medical instruments supplier’s stock worth $6,610,000 after acquiring an additional 2,761 shares during the last quarter. Quantinno Capital Management LP bought a new stake in shares of ICU Medical in the 3rd quarter worth approximately $236,000. Squarepoint Ops LLC lifted its holdings in shares of ICU Medical by 534.3% in the 3rd quarter. Squarepoint Ops LLC now owns 7,155 shares of the medical instruments supplier’s stock worth $1,670,000 after acquiring an additional 6,027 shares during the last quarter. Finally, Inspire Investing LLC bought a new stake in shares of ICU Medical in the 3rd quarter worth approximately $231,000. Hedge funds and other institutional investors own 94.93% of the company’s stock.

ICU Medical Company Profile (NASDAQ:ICUI)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Further Reading

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.